SCHEMBL6578028

SCHEMBL6578028

CCOC(=O)c1ccc(C#Cc2ccc3c(c2)N(c2ccc(C)cc2)CCC3(C)C)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 8/20 0.41
RARA P10276 7/20 0.41
RARG P13631 5/20 0.41
CYP3A4 P08684 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 4/20 0.36
RAB9A P51151 3/20 0.36
LMNA P02545 1/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CASP3 P42574 1/20 0.34
KDM4E B2RXH2 2/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6576434 0.89 RARB (0.48) RARBRARARARGCYP3A4CYP26A1
SCHEMBL6578640 0.88 RARB (0.49) RARBRARARARGCYP3A4KMT2A
SCHEMBL8614817 0.80 RARB (0.52) RARBRARARARGCYP3A4KMT2A
SCHEMBL6578025 0.78 RARB (0.65) RARBRARARARGCYP3A4CYP26A1
SCHEMBL6575676 0.73 RARB (0.39) RARBRARARARGCYP3A4CYP26A1
SCHEMBL19342953 0.73 RARA (0.65) RARBRARARARGCYP3A4KMT2A
SCHEMBL6574397 0.73 RARA (0.37) RARBRARARARG
SCHEMBL5736491 0.73 RARB (0.43) RARBRARARARGCYP3A4KMT2A
SCHEMBL6575692 0.70 MAPK1 (0.53) RARBRARARARGCYP3A4KMT2A
SCHEMBL6574370 0.70 RARB (0.67) RARBRARARARGCYP3A4CYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937045-B1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN INC (US) 2004-04-28 EP disclosed
US-5739338-A SKIN DISORDERS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS, VISION DEFECTS, VIRICIDES, IMMUNOSUPPRESSANTS ALLERGAN (US) 1998-04-14 US disclosed